Analyst consensus rating
Twist Bioscience Analyst Rating: Buy
Direct answer
Twist Bioscience's consensus rating is Buy.
12 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $163.67.
Forecast evidence checked October 16, 2026.
Get free Twist Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $140.00
- Average price target
- $163.67
- High price target
- $215.00
- Low price target
- $45.00
- Low target gap
- -67.9%
- Target upside
- +16.9%
- High target gap
- +53.6%
- Target range width
- 121.4%
- Consensus rating
- Buy
- Analysts
- 12
- Evidence date
- October 16, 2026
- Valid through
- October 23, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Twist Bioscience?
Twist Bioscience has a verified Buy consensus. The same dataset has an average price target of $163.67.
How far are Twist Bioscience's low and high targets from the recorded price?
The low target implies -67.9%, while the high target implies +53.6%.
How many analysts are included in Twist Bioscience's consensus?
The verified consensus includes 12 analysts.
How is Twist Bioscience's target upside or downside calculated?
The average target of $163.67 is divided by the recorded price of $140.00, then one is subtracted to produce +16.9%. This does not guarantee a future return.
When was Twist Bioscience's analyst forecast verified?
The data was verified on 2026-10-16. The dataset is valid through 2026-10-23.